Clinical Trials Underway

Synlogic is currently conducting clinical trials to evaluate the safety and tolerability of our Synthetic Biotic™ medicines to treat phenylketonuria (SYNB1618), and advanced solid tumors and lymphoma (SYNB1891), conditions with unmet medical needs. We are also working to advance new medicines for metabolic diseases and autoimmune and inflammatory diseases.

For Physicians

If you are a physician interested in enrolling your patients or becoming an investigator in a future study, please contact contact-us@synlogictx.com.